NCT00544986View on ClinicalTrials.gov

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Breast Cancer
Interventions
DRUG

Anastrozole

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY